Regulations.gov document
Attachment 2 Horizon Pharma plc Announces Acquisition of U.S. Rights to PENNSAID® 2% From…
Supporting & Related Material · FDA-2016-P-3753 · posted Nov 10, 2016
Key facts
| Document ID | FDA-2016-P-3753-0004 |
|---|---|
| Title | Attachment 2 Horizon Pharma plc Announces Acquisition of U.S. Rights to PENNSAID® 2% From Nuvo Research Inc. re Citizen Petition from Macleods Pharmaceuticals Limited |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2016-P-3753 |
| Posted | Nov 10, 2016 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: